냉동 절제 프로브 시장 규모, 점유율, 동향 분석 보고서 : 용도별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Cryoablation Probe Market Size, Share & Trends Analysis Report By Application (Oncology, Liver Cancer, Dermatology), By End Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers (ASCs)), By Region, And Segment Forecasts, 2025 - 2033

US $ 5,950 ￦ 8,266,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,655,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,434,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

냉동 절제 프로브 시장 요약

냉동 절제 프로브 시장 규모는 2024년에 1억 8,980만 달러에 달했고, 2033년에는 6억 4,684만 달러에 이를 것으로 예측되며, 2025년부터 2033년까지에서의 CAGR은 14.69%를 나타낼 전망입니다. 시장 성장의 배경에는 전립선, 간, 신장, 폐 등의 암 이환율이 상승하여 효과적이고 침습적인 치료에 대한 수요가 높아지고 있는 경우가 있습니다.

냉동 절제는 전통적인 수술에 비해 회복 시간이 짧고 합병증이 적고 미용 효과가 높기 때문에 환자와 건강 관리 제공업체들 사이에서 선호되는 옵션이되었습니다. 프로브 설계, CT 및 MRI 지침과 같은 이미징 기술, 개선된 크라이오젠 제어 시스템의 지속적인 진보는 절차의 정확성과 안전성을 높이고 임상 현장에서의 보급을 더욱 강화하고 있습니다.

특히 전립선암, 간암, 신장암, 폐암 등의 이환율 증가는 냉동 절제 프로브에 대한 수요 증가의 주요 원동력이 되고 있습니다. 냉동 절제는 주위의 건강한 부위에의 데미지를 최소화하면서, 극저온을 이용해 암 조직을 정확하게 노리고, 파괴하는 것으로, 이 요구에 응하는 것입니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 냉동 절제 프로브 시장 변수, 동향 및 범위

• 시장 계통 전망
  • 보조 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 시장 기회 분석
  • 시장 과제 분석
• 냉동 절제 프로브 시장 분석 도구
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석
  • COVID-19의 영향 분석

제4장 냉동 절제 프로브 시장 : 용도 추정·동향 분석

• 부문 대시보드
• 냉동 절제 프로브 시장 : 용도 변동 분석과 시장 점유율(2024년 및 2033년)
• 심장 부정맥
• 종양학
  • 폐암
  • 전립선암
  • 유방암
  • 신장암
  • 간암
• 피부과
• 기타

제5장 냉동 절제 프로브 시장 : 최종 용도 추정·동향 분석

• 부문 대시보드
• 냉동 절제 프로브 시장 : 최종 용도 변동 분석과 시장 점유율(2024년 및 2033년)
• 병원
• 전문 클리닉
• 외래수술센터(ASC)
• 기타

제6장 냉동 절제 프로브 시장 : 지역 추정·동향 분석

• 지역 전망
• 냉동 절제 프로브 시장 : 지역 변동 분석과 시장 점유율(2024년 및 2033년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 시장 진출기업의 분류
• 주요 기업 프로파일
  • Atricure, Inc
  • Varian, A Siemens Healthineers Company
  • Medtronic
  • Metrum Cryoflex
  • HealthTronics, Inc.
  • Erbe Elektromedizin GmbH
  • Keeler
  • Boston Scientific Corporation
  • Bruker
  • IceCure Medical
• 히트맵 분석/기업시장 포지셔닝 분석
• 기업의 시장 점유율 예측 분석(2024년)

KTH

영문 목차

영문목차

Cryoablation Probe Market Summary

The global cryoablation probe market size was estimated at USD 189.80 million in 2024 and is projected to reach USD 646.84 million by 2033, growing at a CAGR of 14.69% from 2025 to 2033. The market's growth is attributed to the rising incidence of cancers such as prostate, liver, kidney, and lung, which increases the demand for effective, minimally invasive treatments.

Cryoablation is becoming a preferred option among patients and healthcare providers because it offers shorter recovery times, fewer complications, and better cosmetic results compared to traditional surgery. In addition, continuous advancements in probe design, imaging technologies like CT and MRI guidance, and improved cryogen control systems enhance the procedure's precision and safety, further supporting its widespread adoption in clinical settings.

The rising incidence of cancers, particularly prostate, liver, kidney, and lung, has become a key driver for the growing demand for cryoablation probes, as these cancers are often treatable with localized, minimally invasive techniques. With the global cancer burden increasing, there is a greater need for treatment options that are effective, safe, and less physically taxing, especially for patients who may not be suitable for traditional surgery due to age, other health conditions, or advanced disease stages. Cryoablation addresses this need by enabling precise targeting and destruction of cancerous tissue using extreme cold, while minimizing damage to surrounding healthy areas. These advantages make cryoablation an increasingly preferred option, fueling the demand for probes in such procedures.

Global Cryoablation Probe Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cryoablation probe market report based onapplication, end use, and region:

• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Cardiac Arrhythmias
• Oncology
  • Lung Cancer
  • Prostate Cancer
  • Breast Cancer
  • Kidney Cancer
  • Liver Cancer
• Dermatology
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Specialty Clinics
• Ambulatory Surgery Centers (ASCs)
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Purchased database.
• 1.5. GVR's internal database
• 1.6. Secondary sources
• 1.7. Third Party Perspective
• 1.8. Primary research
• 1.9. Details of primary research
• 1.10. Information or Data Analysis
• 1.11. Data analysis models
• 1.12. Market Formulation & Validation
• 1.13. Model Details
• 1.14. Commodity flow analysis (Model 1)
• 1.15. Approach 1: Commodity flow approach
• 1.16. Volume price analysis (Model 2)
• 1.17. Approach 2: Volume price analysis
• 1.18. List of Secondary Sources
• 1.19. List of Primary Sources
• 1.20. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Cryoablation Probe Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising cancer incidence
    • 3.2.1.2. Growing preference for minimally invasive procedures
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market Restraint Analysis
  • 3.2.3. Market Opportunities Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Cryoablation Probe Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape
  • 3.3.3. COVID-19 Impact Analysis
    • 3.3.3.1. Disrupted Breast Pump
    • 3.3.3.2. Obstacles in Breast Pump

Chapter 4. Cryoablation Probe Market: Application Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Cryoablation Probe Market: Application Movement Analysis & Market Share, 2024 & 2030
• 4.3. Cardiac Arrhythmias
  • 4.3.1. Cardiac Arrhythmias Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Oncology
  • 4.4.1. Oncology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Lung Cancer
    • 4.4.2.1. Lung Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Prostate Cancer
    • 4.4.3.1. Prostate Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Breast Cancer
    • 4.4.4.1. Breast Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Kidney Cancer
    • 4.4.5.1. Kidney Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.6. Liver Cancer
    • 4.4.6.1. Liver Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Dermatology
  • 4.5.1. Dermatology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Others
  • 4.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Cryoablation Probe Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Cryoablation Probe Market: End Use Movement Analysis & Market Share, 2024 & 2030
• 5.3. Hospitals
  • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Specialty Clinics
  • 5.4.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Ambulatory Surgery Center (ASC)
  • 5.5.1. Ambulatory Surgery Center (ASC) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Cryoablation Probe Market: Regional Estimates & Trend Analysis

• 6.1. Regional Outlook
• 6.2. Cryoablation Probe Market: Regional Movement Analysis & Market Share, 2024 & 2030
• 6.3. North America
  • 6.3.1. North America Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. Key Country Dynamics
    • 6.3.2.2. Competitive Scenario
    • 6.3.2.3. Regulatory Scenario
    • 6.3.2.4. Reimbursement Scenario
    • 6.3.2.5. U.S. Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Canada
    • 6.3.3.1. Key Country Dynamics
    • 6.3.3.2. Competitive Scenario
    • 6.3.3.3. Regulatory Scenario
    • 6.3.3.4. Reimbursement Scenario
    • 6.3.3.5. Canada Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.4. Mexico
    • 6.3.4.1. Key Country Dynamics
    • 6.3.4.2. Competitive Scenario
    • 6.3.4.3. Regulatory Scenario
    • 6.3.4.4. Reimbursement Scenario
    • 6.3.4.5. Mexico Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Europe
  • 6.4.1. Europe Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.2. UK
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Competitive Scenario
    • 6.4.2.3. Regulatory Scenario
    • 6.4.2.4. Reimbursement Scenario
    • 6.4.2.5. UK Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.3. Germany
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Competitive Scenario
    • 6.4.3.3. Regulatory Scenario
    • 6.4.3.4. Reimbursement Scenario
    • 6.4.3.5. Germany Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.4. France
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Competitive Scenario
    • 6.4.4.3. Regulatory Scenario
    • 6.4.4.4. Reimbursement Scenario
    • 6.4.4.5. France Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.5. Italy
    • 6.4.5.1. Key Country Dynamics
    • 6.4.5.2. Competitive Scenario
    • 6.4.5.3. Regulatory Scenario
    • 6.4.5.4. Reimbursement Scenario
    • 6.4.5.5. Italy Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.6. Spain
    • 6.4.6.1. Key Country Dynamics
    • 6.4.6.2. Competitive Scenario
    • 6.4.6.3. Regulatory Scenario
    • 6.4.6.4. Reimbursement Scenario
    • 6.4.6.5. Spain Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.7. Denmark
    • 6.4.7.1. Key Country Dynamics
    • 6.4.7.2. Competitive Scenario
    • 6.4.7.3. Regulatory Scenario
    • 6.4.7.4. Reimbursement Scenario
    • 6.4.7.5. Denmark Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.8. Sweden
    • 6.4.8.1. Key Country Dynamics
    • 6.4.8.2. Competitive Scenario
    • 6.4.8.3. Regulatory Scenario
    • 6.4.8.4. Reimbursement Scenario
    • 6.4.8.5. Sweden Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.9. Norway
    • 6.4.9.1. Key Country Dynamics
    • 6.4.9.2. Competitive Scenario
    • 6.4.9.3. Regulatory Scenario
    • 6.4.9.4. Reimbursement Scenario
    • 6.4.9.5. Norway Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Asia Pacific Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.2. Japan
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Scenario
    • 6.5.2.4. Reimbursement Scenario
    • 6.5.2.5. Japan Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.3. China
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Scenario
    • 6.5.3.4. Reimbursement Scenario
    • 6.5.3.5. China Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.4. India
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Scenario
    • 6.5.4.4. Reimbursement Scenario
    • 6.5.4.5. India Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.5. South Korea
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Competitive Scenario
    • 6.5.5.3. Regulatory Scenario
    • 6.5.5.4. Reimbursement Scenario
    • 6.5.5.5. South Korea Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.6. Australia
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Competitive Scenario
    • 6.5.6.3. Regulatory Scenario
    • 6.5.6.4. Reimbursement Scenario
    • 6.5.6.5. Australia Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.7. Thailand
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Competitive Scenario
    • 6.5.7.3. Regulatory Scenario
    • 6.5.7.4. Reimbursement Scenario
    • 6.5.7.5. Thailand Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Latin America
  • 6.6.1. Latin America Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.2. Brazil
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Scenario
    • 6.6.2.4. Reimbursement Scenario
    • 6.6.2.5. Brazil Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.3. Argentina
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Scenario
    • 6.6.3.4. Reimbursement Scenario
    • 6.6.3.5. Argentina Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Middle East & Africa
  • 6.7.1. Middle East & Africa Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.2. South Africa
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Scenario
    • 6.7.2.4. Reimbursement Scenario
    • 6.7.2.5. South Africa Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.3. Saudi Arabia
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Scenario
    • 6.7.3.4. Reimbursement Scenario
    • 6.7.3.5. Saudi Arabia Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.4. UAE
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Scenario
    • 6.7.4.4. Reimbursement Scenario
    • 6.7.4.5. UAE Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.5. Kuwait
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory Scenario
    • 6.7.5.4. Reimbursement Scenario
    • 6.7.5.5. Kuwait Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. Atricure, Inc
    • 7.2.1.1. Company Overview
    • 7.2.1.2. Financial Performance
    • 7.2.1.3. Product Benchmarking
    • 7.2.1.4. Strategic Initiatives
  • 7.2.2. Varian, A Siemens Healthineers Company
    • 7.2.2.1. Company Overview
    • 7.2.2.2. Financial Performance
    • 7.2.2.3. Product Benchmarking
    • 7.2.2.4. Strategic Initiatives
  • 7.2.3. Medtronic
    • 7.2.3.1. Company Overview
    • 7.2.3.2. Financial Performance
    • 7.2.3.3. Product Benchmarking
    • 7.2.3.4. Strategic Initiatives
  • 7.2.4. Metrum Cryoflex
    • 7.2.4.1. Company Overview
    • 7.2.4.2. Financial Performance
    • 7.2.4.3. Product Benchmarking
    • 7.2.4.4. Strategic Initiatives
  • 7.2.5. HealthTronics, Inc.
    • 7.2.5.1. Company Overview
    • 7.2.5.2. Financial Performance
    • 7.2.5.3. Product Benchmarking
    • 7.2.5.4. Strategic Initiatives
  • 7.2.6. Erbe Elektromedizin GmbH
    • 7.2.6.1. Company Overview
    • 7.2.6.2. Financial Performance
    • 7.2.6.3. Product Benchmarking
    • 7.2.6.4. Strategic Initiatives
  • 7.2.7. Keeler
    • 7.2.7.1. Company Overview
    • 7.2.7.2. Financial Performance
    • 7.2.7.3. Product Benchmarking
    • 7.2.7.4. Strategic Initiatives
  • 7.2.8. Boston Scientific Corporation
    • 7.2.8.1. Company Overview
    • 7.2.8.2. Financial Performance
    • 7.2.8.3. Product Benchmarking
    • 7.2.8.4. Strategic Initiatives
  • 7.2.9. Bruker
    • 7.2.9.1. Company Overview
    • 7.2.9.2. Financial Performance
    • 7.2.9.3. Product Benchmarking
    • 7.2.9.4. Strategic Initiatives
  • 7.2.10. IceCure Medical
    • 7.2.10.1. Company Overview
    • 7.2.10.2. Financial Performance
    • 7.2.10.3. Product Benchmarking
    • 7.2.10.4. Strategic Initiatives
• 7.3. Heat Map Analysis/ Company Market Position Analysis
• 7.4. Estimated Company Market Share Analysis, 2024

관련자료